Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field PRASUGREL
Haematology · Haematology · Level 2
ABCIXIMAB
Haematology · Haematology · Level 3
Mechanism of action

Irreversibly binds the P2Y12-R (an ADP receptor), preventing activation of glycoprotein IIb/IIIa→ prevents platelet crosslinking

Similar mechanism as tirofiban but monoclonal
antibody

Metabolism

Prodrug- 1 step metabolism
Less susceptible to CYP polymorphism and CYP inhibition or induction than Clopidogrel

Platelet function
typically returns to
normal 24-48 hours after
infusion ceases

Excretion —

Platelet function
typically returns to
normal 24-48 hours after
infusion ceases

Adverse Effects Toxicity —

Haemorrhage, thrombocytopenia, human antichimeric antibody development, allergic reaction

Class Group

Antiplatelet

Antiplatelet

Introduction

ADP Receptor Antagonist - Thienopyridine

Prodrug

GP IIb/IIIA Inhibitor

Legacy Cicm Level

Level 3

Level 3

Main Action

Platelet inhibition

Platelet inhibition